The RadScopal Technique as an Immune Adjuvant to Treat Cancer

Since the momentous discovery of X-rays, high-dose radiotherapy (H-XRT) has been a cornerstone for combating cancer. The high-energy electromagnetic waves induce direct damage to tumor-cells’ DNA, thereby halting cell growth and proliferation, and eventually leading to tumor eradication. Furthermore...

Full description

Bibliographic Details
Published in:	Immuno
Main Authors:	Hampartsoum B. Barsoumian, Jerry Hsu, Selene Nanez, Yun Hu, Ethan Y. Hsu, Thomas S. Riad, Nahum Puebla-Osorio, Maria Angelica Cortez, James W. Welsh
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	RadScopal radiotherapy immunotherapy
Online Access:	https://www.mdpi.com/2673-5601/3/1/6

Similar Items

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
by: Camil Ciprian Mireştean, et al.
Published: (2020-12-01)

Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
by: Zhiguang Chen, et al.
Published: (2022-08-01)

RAD51 wrestles with SUMO
by: Younghoon Kee, et al.
Published: (2022-12-01)

Hot on RAD51C: structure and functions of RAD51C‐XRCC3
by: Barnabas Szakal, et al.
Published: (2023-10-01)

Rad52-Rad51 association is essential to protect Rad51 filaments against Srs2, but facultative for filament formation
by: Emilie Ma, et al.
Published: (2018-07-01)

Timski rad
by: Dragutin Sekulić
Published: (1989-01-01)

In silico analysis on the functional and structural impact of Rad50 mutations involved in DNA strand break repair
by: Juwairiah Remali, et al.
Published: (2020-05-01)

ezRAD: a simplified method for genomic genotyping in non-model organisms
by: Robert J. Toonen, et al.
Published: (2013-11-01)

POSITIVE PREDICTIVE VALUES OF THE SONOGRAPHIC BI-RADS FINAL ASSESSMENT CATEGORIES FOR BREAST LESIONS
by: Betül Zengin, et al.
Published: (2013-07-01)

Rad52 Oligomeric N-Terminal Domain Stabilizes Rad51 Nucleoprotein Filaments and Contributes to Their Protection against Srs2
by: Emilie Ma, et al.
Published: (2021-06-01)

The Scopal Authority of Heads in Yoruba-English Code-Switching
by: M. T. Lamidi
Published: (2004-03-01)

TI-RADS: to be or not to be. Polemic notes from the Eurasian Forum on thyroid cancer
by: Alexey V. Borsukov
Published: (2017-03-01)

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls
by: Federica De Muzio, et al.
Published: (2022-07-01)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
by: Cosmin Caraiani, et al.
Published: (2021-05-01)

Arktisk råds rolle i polarpolitikken
by: Torbjørn Pedersen
Published: (2012-05-01)

Radiomics Score Combined with ACR TI-RADS in Discriminating Benign and Malignant Thyroid Nodules Based on Ultrasound Images: A Retrospective Study
by: Peng Luo, et al.
Published: (2021-06-01)

PI-RADS 2.1: A Practical Overview
by: A Dayala Sundaram
Published: (2024-09-01)

Norge og Arktisk råd
by: Serafima Andreeva, et al.
Published: (2025-05-01)

DiscoSnp-RAD: de novo detection of small variants for RAD-Seq population genomics
by: Jérémy Gauthier, et al.
Published: (2020-06-01)

Corrigendum: Lipid metabolism in tumor immunology and immunotherapy
by: Lisa K. Duong, et al.
Published: (2024-01-01)

Lipid metabolism in tumor immunology and immunotherapy
by: Lisa K. Duong, et al.
Published: (2023-05-01)

Grønland, Færøerne og Danmark: Kongeriget Danmarks formandskab i Arktisk Råd, 2025–27
by: Kenneth Høegh
Published: (2025-06-01)

THE IMPACT OF RAD6 EXPRESSION ON CHEMORESISTANT OVARIAN CANCER: A SYSTEMATIC REVIEW
by: Leo Vernadesly, et al.
Published: (2025-01-01)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
by: Yu-Hao Wang, et al.
Published: (2023-01-01)

CT MRI LI-RADS in Routine Practice
by: Karthik Ganesan, et al.
Published: (2023-09-01)

Rad nakon penzionisanja u Srbiji iz antropološke perspektive
by: Ljubica Milosavljevic, et al.
Published: (2023-12-01)

O-RADS MRI risk stratification system: pearls and pitfalls
by: Stephanie Nougaret, et al.
Published: (2024-02-01)

BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases
by: Malwina Suszynska, et al.
Published: (2020-05-01)

Har Arktisk råd noen betydning?
by: Morten Høglund
Published: (2025-05-01)

Histopathological Grading based on BI-RADS Mammography Category 4 and 5 in Breast Cancer
by: Farhan Ubaidillah Ramadhan, et al.
Published: (2025-08-01)

Using ezRAD to reconstruct the complete mitochondrial genome of Porites fontanesii (Cnidaria: Scleractinia)
by: Tullia I. Terraneo, et al.
Published: (2018-01-01)

Rad and Mubad in Shahnameh of Ferdowsi
by: z Delpazir, et al.
Published: (2011-09-01)

Twenty Years of Rad-Hard K14 SPAD in Space Projects
by: Vojtěch Michálek, et al.
Published: (2015-07-01)

Usefulness of for BI-RAD category 4 or Higher Lesions
by: Jun Suk Byun, et al.
Published: (2017-06-01)

Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
by: Kewen He, et al.
Published: (2024-09-01)

Correction: Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
by: Kewen He, et al.
Published: (2024-09-01)

Correlation between BI-RADS 4 and histopathological results in atypical breast lesions
by: Patricio Alonso Jaramillo-Guerrero, et al.
Published: (2023-12-01)

Potencijal za rad mnoštva u knjižnicama i arhivima grada Zagreba
by: Sanja Jurković
Published: (2022-05-01)

Aplikasi Penyesuaian Stock Sebagai Pendukung Proses Audit Pada Perusahaan Manufaktur dengan Metode RAD
by: Ralfpiere Charlitos, et al.
Published: (2023-07-01)

Breast imaging reporting and data system (BI RADS): Why don't we use it correctly in the region?
by: Prvulović-Bunović Nataša, et al.
Published: (2024-01-01)